NCT03417544 2025-04-02Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BCDana-Farber Cancer InstitutePhase 2 Active not recruiting19 enrolled 26 charts
NCT05042791 2024-02-09A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain MetastasesJiangxi Provincial Cancer HospitalPhase 2 Unknown362 enrolled